{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"5FucebsyiS\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/25001\/\">Not\u00edcias e notas de sa\u00fade animal de 22 de novembro de 2000<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/25001\/embed\/#?secret=5FucebsyiS\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for November 22, 2000&#8221; &#8212; Brakke Consulting Website\" data-secret=\"5FucebsyiS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 22, 2000 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Visit Brakke Consulting&rsquo;s newly updated website at https:\/\/brakkeconsulting.com\/!&nbsp; We&rsquo;ve improved the site navigation, added a site search feature, and expanded our industry links page.&nbsp; You can also access the most up-to-date information about our syndicated studies, as well as descriptions of all our services. **************************************************************** Company News Releases &gt;&nbsp; Oncolytics Biotech Inc announced that it has entered into a worldwide licensing agreement with US based pharmaceutical firm, Pfizer Inc., for the development and marketing of ONC&rsquo;s reovirus for animal use. The reovirus has shown effectiveness in a number of animal model studies including canine. Pfizer will be responsible for development and commercialization of the product. ONC will provide continuing support to Pfizer for the development of the product. The terms of the agreement were not disclosed. (Business Wire) &gt;&nbsp; AVANT Immunotherapeutics, Inc. announced that the company has entered into a definitive agreement to purchase privately held vaccine company, Megan Health, Inc. in a transaction valued at approximately $18 million.&nbsp; The transaction has been approved by the boards of directors of both companies and by a majority of Megan&rsquo;s shareholders, and is expected to close shortly.&nbsp; The acquisition of Megan adds significantly to AVANT&rsquo;s vaccine portfolio, giving the company a premier position inView Full Post;"}